Pharmacists in Stansbury Park, UT Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Adam Webster, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Millpond Ste 100, Stansbury Park, UT 84074 Phone: 435-843-3050 |
 Ms. Fei Yue Zhang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Millpond Ste 100, Stansbury Park, UT 84074 Phone: 435-843-3052 Fax: 435-843-3055 |
Ms. Marianne Mabey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Millpond Ste 100, Stansbury Park, UT 84074 Phone: 435-843-3052 Fax: 435-843-3055 |
Dr. William Mcmichael Payne Ii, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 71 Lakeview, Stansbury Park, UT 84074 Phone: 435-882-7933 |
Nathan Kristopher Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6013 Hull Ct, Stansbury Park, UT 84074 Phone: 801-971-4874 |
News Archive
Constellation Pharmaceuticals raises $22 million in Series B financing round
Constellation Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing new drugs targeting epigenetic regulation of the human genome, today announced that it has raised $22 million in a Series B financing round.
Proteomics yields new drug targets for treating cardiogenic shock
When it comes to cell signaling and bioregulation, it's tough to find a more important molecule than nitric oxide (NO). Dysfunction of NO-mediated signaling is thought to be a culprit in lethal cardiovascular conditions such as angina, and septic, cardiogenic and hemorrhagic shock; it may play a role in many other illnesses as well.
Universal Health Services announces net income of $174.3 million for first quarter 2015
Universal Health Services, Inc. announced today that its reported net income attributable to UHS was $174.3 million, or $1.73 per diluted share, during the first quarter of 2015 as compared to $138.1 million, or $1.38 per diluted share, during the comparable quarter of 2014.
Sangamo BioSciences fourth quarter revenues increase to $8.9 million
Sangamo BioSciences, Inc. today reported fourth quarter and full year 2012 financial results and accomplishments.
Researchers analyze molecular characteristics of cerebrospinal fluid from LMM patients
Patients with advanced melanoma who develop metastases in the leptomeninges, the fluid filled membranes surrounding the brain and spinal cord, have an extremely dismal prognosis. Most patients only survive for 8 to 10 weeks after diagnosis.
› Verified 8 days ago
Dentists
Pharmacists
Clinical Social Workers
Counselors
Marriage Counselors